MedTrace Logo

Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI

NCT04149990 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2025-01-29

No results posted yet for this study

Summary

This study examines the effect of Entresto on central hemodynamic parameters during exercise in patients with diastolic dysfunction following acute myocardial infarction. Half of the patients will receive Entresto and the other half will receive placebo.

Conditions

Interventions

DRUG

Entresto Pill

NO other interventions

Sponsors & Collaborators

  • Danish Heart Foundation

    collaborator OTHER

  • Odense University Hospital

    collaborator OTHER

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Jacob Moller

    lead OTHER

Principal Investigators

  • Peter Hartmund Frederiksen, DMSC · Odense University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-12
Primary Completion
2022-07-06
Completion
2023-06-06

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04149990 on ClinicalTrials.gov